1-8 of 8
Heinz-Herbert Fiebig
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Influence of Different Genetic Alterations On the Engraftment Capacity and Serial Transplantation Efficiency of AML Patient-Derived Bone Marrow and Peripheral Blood Cells in NSG Mice

Julia Schüler, Peter Haas, MD, Kerstin Klingner, Björn W. Hackanson, MD, Heinz-Herbert Fiebig, Michael Lübbert, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3511.
https://doi.org/10.1182/blood.V120.21.3511.3511
Published: 2012
Journal Articles

Profiling of 24 Standard of Care Drugs in a Panel of 20 Human Hematological Cell Lines Using Xenograft-Derived Three-Dimensional (3D) Cultures Ex Vivo and In Vivo

Armin Maier, Monika Engelhardt, MD, Heinz-Herbert Fiebig, Julia Schüler
Journal: Blood
Blood (2011) 118 (21): 4995.
https://doi.org/10.1182/blood.V118.21.4995.4995
Published: 2011
Journal Articles

Enhanced Antitumoral Activity of Sorafenib or Cetuximab In Comparison to Etoposide In a Disseminated Human AML Model In Vivo

Julia Schüler, Kerstin Klingner, Katja Zirlik, MD, Heinz-Herbert Fiebig, Joachim Böhm
Journal: Blood
Blood (2010) 116 (21): 2141.
https://doi.org/10.1182/blood.V116.21.2141.2141
Published: 2010
Journal Articles

Engraftment Capacity of Intratibialy Injected Multiple Myeloma Patient-Derived Bone Marrow-Cells In Vivo

Julia Schüler, Dagmar Wider, Kerstin Klingner, Heinz-Herbert Fiebig, Monika Engelhardt
Journal: Blood
Blood (2010) 116 (21): 3010.
https://doi.org/10.1182/blood.V116.21.3010.3010
Published: 2010
Journal Articles

In Vivo Efficacy of Peptide-Derived B Cell Receptor (BCR) Targeted Therapy In a Disseminated Burkitt′s Lymphoma Xenograft Modell

Claudia Wehr, Julia Schüler, Claudia Nitschke, Kerstin Klingner, Fabian Müller, Heinz-Herbert Fiebig, Roland H. Mertelsmann, MD, PhD, Martin Trepel, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3924.
https://doi.org/10.1182/blood.V116.21.3924.3924
Published: 2010
Journal Articles

Antitumor Activity of Small-Molecule SYK Inhibitor R788 and Fludarabinin Mono- and Combined Therapy in a Human B-CLL Xenograft Model.

Julia Schüler, Maike Buchner, Heinz-Herbert Fiebig, Hendrik Veelken, Katja Zirlik, MD
Journal: Blood
Blood (2009) 114 (22): 2378.
https://doi.org/10.1182/blood.V114.22.2378.2378
Published: 2009
Journal Articles

“Antitumor Activity of Novel Anti-MM Agents and Combinations, the Proteasome Inhibitor Bortezomib and Multikinase Inhibitor Sorafenib, Both Applied as Monotherapy and in Combination in NOD/SCID-IL2-Receptor-Gamma-chain −/− (NSG) Mice Using a Intratibial Tumor Dissemination approach”.

Julia Schüler, Dagmar Wider, Dietmar Pfeifer, Josefina Udi, Heinz-Herbert Fiebig, Ralph M. Waesch, Monika Engelhardt
Journal: Blood
Blood (2009) 114 (22): 4912.
https://doi.org/10.1182/blood.V114.22.4912.4912
Published: 2009
Journal Articles

Antitumor Activity in a Human Multiple Myeloma (MM) Model Using Sorafenib, Bortezomib, and Dexamethasone Treatment.

Julia Schüler, Dagmar Wider, Dietmar Pfeifer, Martin Wagner, Heinz-Herbert Fiebig, Monika Engelhardt
Journal: Blood
Blood (2008) 112 (11): 1720.
https://doi.org/10.1182/blood.V112.11.1720.1720
Published: 2008